147 related articles for article (PubMed ID: 18819233)
1. [Physiopathologic aspects of anemia and thrombocytopenia in children with cancers: the roles of erythropoietin and thrombopoietin].
Corazza FV
Bull Mem Acad R Med Belg; 2008; 163(1-2):152-6; discussion 156-7. PubMed ID: 18819233
[TBL] [Abstract][Full Text] [Related]
2. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
3. Haematological abnormalities in early abstinent alcoholics are closely associated with alterations in thrombopoietin and erythropoietin serum profiles.
Schmitt M; Gleiter CH; Nichol JL; Pralle L; Hasselblatt M; Poser W; Ehrenreich H
Thromb Haemost; 1999 Nov; 82(5):1422-7. PubMed ID: 10595631
[TBL] [Abstract][Full Text] [Related]
4. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
Rios R; Sangro B; Herrero I; Quiroga J; Prieto J
Am J Gastroenterol; 2005 Jun; 100(6):1311-6. PubMed ID: 15929762
[TBL] [Abstract][Full Text] [Related]
5. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
6. Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia.
Gonen C; Haznedaroglu IC; Aksu S; Koca E; Göker H; Büyükaşik Y; Sayinalp N; Ozcebe O; Dündar S
Platelets; 2005 Feb; 16(1):31-7. PubMed ID: 15763894
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing murine thrombopoietin develop myelofibrosis and osteosclerosis.
Kakumitsu H; Kamezaki K; Shimoda K; Karube K; Haro T; Numata A; Shide K; Matsuda T; Oshima K; Harada M
Leuk Res; 2005 Jul; 29(7):761-9. PubMed ID: 15927672
[TBL] [Abstract][Full Text] [Related]
8. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
[TBL] [Abstract][Full Text] [Related]
9. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
10. A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl.
Tecuceanu N; Dardik R; Rabizadeh E; Raanani P; Inbal A
Br J Haematol; 2006 Nov; 135(3):348-51. PubMed ID: 16995886
[TBL] [Abstract][Full Text] [Related]
11. Anemia in cancer patients.
Ludwig H; Fritz E
Semin Oncol; 1998 Jun; 25(3 Suppl 7):2-6. PubMed ID: 9671322
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia associated with chronic liver disease.
Afdhal N; McHutchison J; Brown R; Jacobson I; Manns M; Poordad F; Weksler B; Esteban R
J Hepatol; 2008 Jun; 48(6):1000-7. PubMed ID: 18433919
[TBL] [Abstract][Full Text] [Related]
13. Construction of a fusion protein between N-terminal 153 peptide of thrombopoietin and erythropoietin.
Lu B; Liu X; Huang P
Sci China C Life Sci; 1998 Aug; 41(4):426-34. PubMed ID: 18726261
[TBL] [Abstract][Full Text] [Related]
14. Scope of growth factor in cancer patients.
Parvez T; Almazaini A; Al Bouq Y; Al-Hazmi OA; Al-Ahmadi YM
J Coll Physicians Surg Pak; 2005 Jun; 15(6):375-7. PubMed ID: 15924849
[TBL] [Abstract][Full Text] [Related]
15. To give or not to give recombinant EPO to anemia endangered cancer patients.
Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
[TBL] [Abstract][Full Text] [Related]
16. [The influence of thrombopoietin (TpO) on human erythropoiesis. In vitro studies--clinical implications].
Machaliński B; Marlicz W; Płuciennik E; Ratajczak J; Ratajczak MZ
Pol Arch Med Wewn; 1997 Apr; 97(4):307-15. PubMed ID: 9411407
[TBL] [Abstract][Full Text] [Related]
17. The role of the liver in the production of thrombopoietin compared with erythropoietin.
Jelkmann W
Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):791-801. PubMed ID: 11474308
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin level in patients with acute leukaemia.
Pavlović-Kentera V; Stefanović S; Milenković P; Jancić M; Biljanović-Paunović L
Haematologia (Budap); 1976; 10(3-4):455-62. PubMed ID: 1072211
[TBL] [Abstract][Full Text] [Related]
19. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
[TBL] [Abstract][Full Text] [Related]
20. [Erythropoietin: indications and measurement].
Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]